Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Director departure
Appointed director
Notes underwriting agrmnt

Protea Biosciences Group, Inc. (PRGB) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/05/2017 8-K Filed for Chapter 11
12/01/2017 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/14/2017 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
11/13/2017 8-K Termination of a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation o...
Docs: "November 7, 2017 letter of termination of license agreements from The George Washington University",
"November 9, 2017 notice of default and reservation of rights letter from counsel to Summit Resources, Inc"
10/26/2017 8-K Quarterly results
10/16/2017 8-K Quarterly results
10/04/2017 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
09/29/2017 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Investor Presentation, dated September 2017"
09/11/2017 PRE 14A Form PRE 14A - Other preliminary proxy statements:
08/29/2017 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
08/25/2017 8-K Quarterly results
08/18/2017 10-Q Quarterly Report for the period ended June 30, 2017
08/14/2017 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
06/28/2017 8-K Form 8-K - Current report
05/19/2017 10-Q Quarterly Report for the period ended March 31, 2017
05/15/2017 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
04/24/2017 8-K Form 8-K - Current report
04/14/2017 10-K Annual Report for the period ended December 31, 2016
04/05/2017 8-K Form 8-K - Current report
04/04/2017 8-K Form 8-K - Current report
04/04/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/04/2017 4 ANTOLINE STEVE (10% Owner) has filed a Form 4 on Protea Biosciences Group, Inc.
Txns: Acquired 16,564,248 shares @ $0
Acquired 16,564,248 options to buy @ $0
04/04/2017 4 HOSTLER STANLEY (Secretary) has filed a Form 4 on Protea Biosciences Group, Inc.
Txns: Acquired 6,000,000 shares @ $0
Acquired 3,333,333 shares @ $0
Acquired 6,000,000 options to buy @ $0
Acquired 3,333,333 options to buy @ $0
04/04/2017 4 SEGAL SCOTT (Director) has filed a Form 4 on Protea Biosciences Group, Inc.
Txns: Acquired 1,000,000 shares @ $0
Acquired 1,000,000 options to buy @ $0
04/04/2017 4 HARRIS LEONARD P (Director) has filed a Form 4 on Protea Biosciences Group, Inc.
03/31/2017 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
03/28/2017 8-K Form 8-K - Current report
03/02/2017 DEF 14A Form DEF 14A - Other definitive proxy statements:
02/23/2017 PRER14A Form PRER14A - Preliminary Proxy Soliciting materials
02/21/2017 PRER14A Form PRER14A - Preliminary Proxy Soliciting materials
02/09/2017 PRE 14A Form PRE 14A - Other preliminary proxy statements
12/16/2016 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
11/21/2016 10-Q Quarterly Report for the period ended September 30, 2016
11/17/2016 D Form D - Notice of Exempt Offering of Securities
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy